ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

ClinicalTrials.gov ID: NCT04663321

Public ClinicalTrials.gov record NCT04663321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 12:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression

Study identification

NCT ID
NCT04663321
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
99 participants

Conditions and interventions

Interventions

  • MK-1942 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 19, 2021
Primary completion
Sep 7, 2023
Completion
Sep 7, 2023
Last update posted
May 3, 2026

2021 – 2023

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
University of Alabama at Birmingham - School of Medicine-Psychiatry ( Site 1073) Birmingham Alabama 35233
Preferred Research Partners ( Site 1079) Little Rock Arkansas 72211
Woodland International Research Group ( Site 1017) Little Rock Arkansas 72211
CITrials-Outpatient Facility ( Site 1098) Bellflower California 90706
Axiom Research ( Site 1053) Colton California 92324
Collaborative Neuroscience Network, LLC. ( Site 1032) Garden Grove California 92845
CITrials ( Site 1105) Santa Ana California 92705
Institute of Living ( Site 1061) Hartford Connecticut 06106
Gulfcoast Clinical Research Center ( Site 1110) Fort Myers Florida 33912
Velocity Clinical Research, Hallandale Beach ( Site 1116) Hallandale Florida 33009
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare ( Site 1039) Jacksonville Florida 32256
Innovative Clinical Research ( Site 1044) Lauderhill Florida 33319
Behavioral Clinical Research ( Site 1037) Miami Florida 33016
Aqualane Clinical Research ( Site 1113) Naples Florida 34105
APG RESEARCH, LLC ( Site 1087) Orlando Florida 32803
University of South Florida-Psychiatry and Behavioral Neurosciences ( Site 1093) Tampa Florida 33613
K2 Medical Research - Winter Park ( Site 1115) Winter Park Florida 32792
Atlanta Center for Medical Research ( Site 1022) Atlanta Georgia 30331
iResearch Atlanta ( Site 1040) Decatur Georgia 30030
Psych Atlanta ( Site 1108) Marietta Georgia 30060
iResearch Savannah ( Site 1041) Savannah Georgia 31405
Ascension Saint Elizabeth ( Site 1003) Chicago Illinois 60622
CBH Health ( Site 1076) Gaithersburg Maryland 20877
Boston Clinical Trials ( Site 1028) Boston Massachusetts 02131
University of Michigan-Psychiatry ( Site 1051) Ann Arbor Michigan 48026
Altea Research ( Site 1018) Las Vegas Nevada 89102
Hassman Research Institute ( Site 1036) Berlin New Jersey 08009
Global Medical Institutes LLC; Princeton Medical Institute ( Site 1049) Princeton New Jersey 08540
Albuquerque Neuroscience Inc. ( Site 1107) Albuquerque New Mexico 87109
Hapworth Research Inc.-Clinical Research Department ( Site 1090) New York New York 10022
Manhattan Behavioral Medicine ( Site 1096) New York New York 10036
Richmond Behavioral Associates ( Site 1011) Staten Island New York 10314
New Hope Clinical Research ( Site 1082) Charlotte North Carolina 28211
Clinical Trials of America, LLC ( Site 1103) Hickory North Carolina 28601
Neuro-Behavioral Clinical Research ( Site 1045) North Canton Ohio 44720
Paradigm Research Professionals ( Site 1089) Oklahoma City Oklahoma 73118
Suburban Research Associates-Clinical Research ( Site 1042) Media Pennsylvania 19063
Penn Medicine: University of Pennsylvania Health System-Mood Disorders Treatment and Research Proga Philadelphia Pennsylvania 19104
Keystone Clinical Studies ( Site 1031) Plymouth Meeting Pennsylvania 19462
Baylor College of Medicine ( Site 1019) Houston Texas 77030
AIM Trials, LLC ( Site 1111) Plano Texas 75093
Cedar Clinical Research ( Site 1023) Draper Utah 84020
Woodstock Research Center ( Site 1084) Woodstock Vermont 05091
Northwest Clinical Research Center ( Site 1112) Bellevue Washington 98007
Core Clinical Research ( Site 1081) Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04663321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04663321 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →